The Team


Yi Li


Chief Scientific Officer


Dr. Li is the Chief Scientific Officer of Axis Therapeutics. He also serves as the Chief Scientific Officer of Xiangxue Life Sciences Limited. He has also held the roles of Chairman of Guangzhou Xiangxue Precision Medical Technology Co., Ltd., President of Guangzhou Xiangxue Pharmaceutical Life Science Center, Research Fellow of Guangzhou Institute of Biomedicine and Health (GIBH), Chinese Academy of Sciences, and National Key Program of Respiratory Diseases, Guangzhou, China Laboratory researcher. Dr. Li graduated from the Hunan Medical University (Xiangya) and received his Ph.D. from the University of Leicester College of Life Sciences. He spent about 20 years in UK doing antibody and T cell receptor research. His main research focused on developing TCR-based immunotherapy. His works were published in Nature Biotechnology, Nature Medicine, JBC, Molecular Cancer Therapy, and many others.